| Biopsy Outcome . | N (%) . |
|---|---|
| Invasive ductal carcinoma | 8 (26.7%) |
| Ductal carcinoma in situ | 3 (10.0%) |
| Non-specific benign breast tissue | 4 (13.3%) |
| Fibroadenoma | 6 (20%) |
| Tubular adenoma | 2 (6.7%) |
| Adenosis | 3 (10%) |
| Phyllodes tumor | 1 (3.3%) |
| Invasive lobular carcinoma | 1 (3.3%) |
| Ductal hyperplasia | 1 (3.3%) |
| Non-specific malignant disease | 1 (3.3%) |
| Total | 30 (99.9%) |
| Biopsy Outcome . | N (%) . |
|---|---|
| Invasive ductal carcinoma | 8 (26.7%) |
| Ductal carcinoma in situ | 3 (10.0%) |
| Non-specific benign breast tissue | 4 (13.3%) |
| Fibroadenoma | 6 (20%) |
| Tubular adenoma | 2 (6.7%) |
| Adenosis | 3 (10%) |
| Phyllodes tumor | 1 (3.3%) |
| Invasive lobular carcinoma | 1 (3.3%) |
| Ductal hyperplasia | 1 (3.3%) |
| Non-specific malignant disease | 1 (3.3%) |
| Total | 30 (99.9%) |
| Biopsy Outcome . | N (%) . |
|---|---|
| Invasive ductal carcinoma | 8 (26.7%) |
| Ductal carcinoma in situ | 3 (10.0%) |
| Non-specific benign breast tissue | 4 (13.3%) |
| Fibroadenoma | 6 (20%) |
| Tubular adenoma | 2 (6.7%) |
| Adenosis | 3 (10%) |
| Phyllodes tumor | 1 (3.3%) |
| Invasive lobular carcinoma | 1 (3.3%) |
| Ductal hyperplasia | 1 (3.3%) |
| Non-specific malignant disease | 1 (3.3%) |
| Total | 30 (99.9%) |
| Biopsy Outcome . | N (%) . |
|---|---|
| Invasive ductal carcinoma | 8 (26.7%) |
| Ductal carcinoma in situ | 3 (10.0%) |
| Non-specific benign breast tissue | 4 (13.3%) |
| Fibroadenoma | 6 (20%) |
| Tubular adenoma | 2 (6.7%) |
| Adenosis | 3 (10%) |
| Phyllodes tumor | 1 (3.3%) |
| Invasive lobular carcinoma | 1 (3.3%) |
| Ductal hyperplasia | 1 (3.3%) |
| Non-specific malignant disease | 1 (3.3%) |
| Total | 30 (99.9%) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
